Reporting
CTN 308: Estrogen and Probiotic Treatment for Vaginal Health
Improving vaginal health to decrease biological risk of HIV-1 infection in Canadian ACB women
Learn MoreReporting
Improving vaginal health to decrease biological risk of HIV-1 infection in Canadian ACB women
Learn MoreStart-up
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses
Learn MoreStart-up
Contextual Analysis of Urban and Rural Programs and Supports for First Nations and Métis People Living with HIV and other STBBIs
Learn MoreReporting
Development of a Rural Model (DRUM) for Integrated Shared Care in First Nation and Métis Communities
Learn MoreOngoing
HIV Prevention for Gay, Bisexual, and other Men Who Have Sex with Men
Learn MoreReporting
Optimizing the delivery of HIV post-exposure prophylaxis: A randomized controlled trial of text messaging support and physician to nurse task-shifting
Learn MoreCompleted
Motivational Interviewing in Conjunction with Rapid HIV Testing
Learn MoreReporting
A small group intervention to reduce HIV sexual transmission risk behaviour among HIV-positive men who have sex with men: Gay Positive Sex (GPS)
Learn MoreCompleted
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.